ストックスクリーナーアプリを入手
22.97
2.16%
0.51
前日終値:
$22.46
開ける：
$22.44
24時間の取引高:
77,032
Relative Volume:
0.14
時価総額：
$1.11B
収益：
$441.33M
当期純損益:
$9.76M
株価収益率:
114.96
EPS:
0.1998
ネットキャッシュフロー:
$839.00K
1週間 パフォーマンス:
+0.95%
1か月 パフォーマンス:
-39.23%
6か月 パフォーマンス:
-50.69%
1年 パフォーマンス:
-19.80%
1日の値動き範囲:
$22.13
$23.05
1週間の範囲:
$21.76
$23.16
52週間の値動き範囲:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Compare AORT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
22.94 | 1.09B | 441.33M | 9.76M | 839.00K | 0.1998 |
ABT
Abbott Laboratories
|
86.52 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.28 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.02 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.91 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.11 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | 開始されました | Canaccord Genuity | Buy |
| 2024-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-27 | 繰り返されました | Lake Street | Buy |
| 2022-08-08 | 開始されました | Lake Street | Buy |
| 2022-03-03 | 開始されました | Stifel | Buy |
すべてを表示
Artivion Inc (AORT) 最新ニュース
Artivion Q1 earnings call highlights - MSN
Artivion secures FDA approval for NEXUS aortic arch system - MSN
Artivion (AORT) Q1 earnings and revenues surpass estimates - MSN
Artivion (AORT) director corrects details of restricted stock award - Stock Titan
Artivion (AORT) director receives 7,576-share equity RSA grant - Stock Titan
Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System - MedTech Intelligence
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Yahoo Finance
Artivion (AORT) director receives 7,850-share stock award, now holds 56,938 - Stock Titan
Artivion Earnings Call Balances Growth With Caution - TipRanks
Artivion closes Endospan buyout to acquire recently approved heart device - MedTech Dive
Artivion Bets On Full Aortic Arch Suite After Endospan Deal - Yahoo Finance
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition - MSN
Artivion (AORT) Completes Acquisition of Endospan for Aortic Sol - GuruFocus
Artivion Closes $175 Million Acquisition of Endospan - Moomoo
Artivion Completes Acquisition of Endospan, Secures FDA Approval for NEXUS Aortic Arch System - Minichart
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
Artivion Closes $175M Deal for Aortic Arch Maker Endospan - Medical Product Outsourcing
Artivion completes $175M acquisition of Endospan - Investing.com UK
Artivion completes $175M acquisition of Endospan By Investing.com - Investing.com South Africa
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System - BioSpace
Artivion Closes Endospan Acquisition Following FDA Approval of NEXUS Aortic System - citybiz
Artivion completes $135 million Endospan acquisition - Investing.com
Artivion completes $135 million Endospan acquisition By Investing.com - Investing.com Australia
Artivion Completes Strategic Acquisition of Endospan Platform - TipRanks
Artivion completes acquisition of Endospan; $131.3M net upfront, up to $200M contingent - TradingView
Endospan acquisition gives Artivion (NYSE: AORT) FDA-approved NEXUS aortic arch system - Stock Titan
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS - Business Wire
Aortic surgery firm Artivion buys Endospan, NEXUS arch stent maker - Stock Titan
Artivion Completes Acquisition of Endospan Ltd. - PR Newswire
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding - The Motley Fool
Artivion Q1 2026 Earnings: Revenue Matches Estimates, EPS Misses by 35%News and Statistics - IndexBox
5 Insightful Analyst Questions From Artivion’s Q1 Earnings Call - Yahoo Finance
Artivion, Inc. (NYSE:AORT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Artivion shareholders elect directors and approve executive compensation By Investing.com - Investing.com Nigeria
Artivion shareholders elect directors and approve executive compensation - Investing.com
Artivion Shareholders Back Board, Pay and Auditor Choices - TipRanks
Artivion (AORT) shareholders approve directors, executive pay and Ernst & Young for 2026 - Stock Titan
UBS Group AG Has $12.76 Million Position in Artivion, Inc. $AORT - MarketBeat
Artivion Inc (AORT) Shares Surge 3.1% -- What GF Score of 86 Tel - GuruFocus
Artivion Inc (AORT) Shares Surge 3.1% -- What GF Score of 86 Tells Investors - GuruFocus
Artivion (AORT) price target decreased by 16.86% to 43.73 - MSN
Artivion Inc (AORT) 財務データ
収益
当期純利益
現金流量
EPS
0.32%
0.17%
大文字化:
|
ボリューム (24 時間):